Leede Financial Downgrades Premier Health of America (CVE:PHA) to Moderate Buy

Premier Health of America (CVE:PHA) was downgraded by Leede Financial from a “strong-buy” rating to a “moderate buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports.

Separately, Acumen Capital cut their price target on Premier Health of America from C$0.95 to C$0.65 and set a “speculative buy” rating for the company in a report on Monday, May 27th.

Premier Health of America Price Performance

Shares of Premier Health of America stock opened at C$0.21 on Thursday. The business has a fifty day simple moving average of C$0.35 and a two-hundred day simple moving average of C$0.44. Premier Health of America has a 1 year low of C$0.18 and a 1 year high of C$0.67. The company has a market capitalization of C$11.66 million, a price-to-earnings ratio of -3.50 and a beta of 0.59.

Premier Health of America (CVE:PHA) last announced its quarterly earnings results on Thursday, May 23rd. The company reported C($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.01 by C($0.04). Premier Health of America had a negative net margin of 2.42% and a negative return on equity of 19.27%. The business had revenue of C$46.28 million for the quarter, compared to analyst estimates of C$41.50 million. As a group, equities analysts anticipate that Premier Health of America will post 0.0100083 earnings per share for the current fiscal year.

Premier Health of America Company Profile

Premier Health of America Inc, together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes.